Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | INT-1B3 |
Synonyms | |
Therapy Description |
INT-1B3 is a nanoparticle formulation of an miRNA targeting WT1 (miR-193a-3p), which potentially inhibits tumor growth (PMID: 33747358, Blood (2022) 140 (Supplement 1): 6224-6225). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
INT-1B3 | INT 1B3|INT1B3 | INT-1B3 is a nanoparticle formulation of an miRNA targeting WT1 (miR-193a-3p), which potentially inhibits tumor growth (PMID: 33747358, Blood (2022) 140 (Supplement 1): 6224-6225). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04675996 | Phase I | INT-1B3 | First-in-Human Study of INT-1B3 in Patients With Advanced Solid Tumors | Terminated | NLD | BEL | 0 |